Creative Biolabs-Immuno-oncology

Anti-CD20 (clone B3L22D) SynExpress la-Cy2-GR-B CD4+ T Cells (CAT#: ITS-1124-CR486)

DatasheetDatasheet
Description
This product utilizes CD4+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD20 ( clone B3L22D). We employs the Lentivirus (lac-Cy2-GR-BamHI) vector components and the SynExpress system of the exons RNA Editing/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
CD20
Clone
B3L22D
Species Reactivity
Human
Cell Source
Synthetic CD4+ T cells
Sensor Gene
Cy2
Promoter
lac
Effector Gene
GR
Insertion Sites
BamHI
Gene Modification
RNA Editing
Modification Domain
Exons
Carrier Type
Lentivirus
Transformation Accuracy
0.86
Cell Culture
Suspension Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving